Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB vs IV PCA for Multiple Rib Fracture Pain
NCT05975294Unknown
- Sponsor
- Sohag University
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection and fentanyl in rib fracture (2 arms), sponsored by Sohag University. Primary endpoints: Mean change in incentive spirometry volume at 1 year and Visual Analog Scale pain score at 1 year. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injectionfentanyl
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT05975294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05975294.